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Abstract
The first wave (FW) of COVID-19 led to a rapid reduction in total emergency department (ED) visits and hospital admis-
sions for other diseases. Whether this represented a transient “lockdown and fear” phenomenon, or a more persisting trend, 
is unknown. We divided acute from post-wave changes in ED flows, diagnoses, and hospital admissions, in an Italian city 
experiencing a FW peak followed by nadir. This multicenter, retrospective, cross-sectional study involved five general EDs 
of a large Italian city (January–August 2020). Percent changes were calculated versus 2019, using four 14-day periods (FW 
peak, early/mid/late post-wave). ED visits were 147,446 in 2020, versus 214,868 in 2019. During the FW peak, visits were 
reduced by 66.4% (P < 0.001). The drop was maximum during daytime (69.8%) and for pediatric patients (89.4%). Critical 
triage codes were unchanged. Reductions were found for all non-COVID-19 diagnoses. Non-COVID-19 hospital admissions 
were reduced by 39.5% (P < 0.001), involving all conditions except hematologic, metabolic/endocrine, respiratory diseases, 
and traumas. In the early, mid, and late post-wave periods, visits were reduced by 25.4%, 25.3% and 23.5% (all P < 0.001) 
respectively. In the late period, reduction was greater for female (27.9%) and pediatric patients (44.6%). Most critical triage 
codes were unchanged. Oncological, metabolic/endocrine, and hematological diagnoses were unchanged, while other diag-
noses had persistent reductions. Non-COVID-19 hospital admissions were reduced by 12.8% (P = 0.001), 6.3% (P = 0.1) and 
12.2% (P = 0.001), respectively. Reductions in ED flows, led by non-critical codes, persisted throughout the summer nadir 
of COVID-19. Hospital admissions for non-COVID-19 diseases had transient changes.
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Introduction
The first diffusion wave of COVID-19 in early 2020 led to 
a steep decline in total Emergency Department (ED) visits, 
contradicting previous experience with seasonal influenza 
and ED overcrowding [1–4]. This unpredicted phenom-
enon involved acute drops in the diagnoses and hospital 
admissions for time-dependent conditions, raising major 
clinical concerns [5–8]. However, cross-sectional details 
regarding ED visit characteristics, diagnostic outcomes, 
and disposed hospital admissions, have been sparse, and 
reports have focused on the initial phase of the COVID-
19 pandemic, when the first lockdown measures were 
disposed. In several countries, especially in Europe, an 
epidemiological post-wave nadir phase devoid of lock-
down measures was registered during the summer of 
2020. Trends in ED flows and activity after the first wave, 
beyond the initial “public fear and lockdown” response, 
are unknown. Understanding the dynamics and kinetics of 
this phenomenon is instrumental to guide organization of 
EDs, medical wards and hospital care at large, during and 
beyond the second wave of COVID-19.
In the city of Torino, a large northern Italian city 
(870,000 inhabitants), during the first wave of the pan-
demic, the number of daily COVID-19 diagnoses peaked 
in March–April 2020. Since June, a persistently low inci-
dence was registered throughout the summer of 2020, when 
restrictive measures were withdrawn. We took advantage 
of this epidemiological scenario, characterized by a well-
defined first wave and post-wave nadir phase, to evaluate ED 
flows, visit characteristics, diagnoses, and hospital admis-
sions, during the first wave and in the post-wave phase. Our 
working hypothesis was that these variables would return 
to previous standards after the resolution of the first wave 
and withdrawal of lockdown measures. Persistent changes, 
instead, would prompt to structural and long-lasting effects 
of the pandemics on use of/referral to EDs.
Methods
Study design and setting
We conducted a multicenter, observational, retrospective 
study in five hospitals in the urban area of Torino, Italy, 
covering all medical and surgical specialties. Participating 
centers (ESM Appendix Table 1) were: one large tertiary 
university hospital (coordinating center), one tertiary non-
university hospital, two secondary non-university hospi-
tals and one smaller community hospital. All are public 
hospitals (except for the latter, which is private providing 
public healthcare). The overall census of the participating 
EDs is about 320.000 ED visits/year (pre-COVID-19 
period), corresponding to ≈ 90% of ED visits in the urban 
area. Urban hospitals not participating to the present study 
were one small community hospital, a specialty trauma 
center, a specialty obstetrical/gynecological center and a 
specialty pediatric center.
Epidemiological scenario and lockdown timing
During the first wave of the pandemic, the national peak 
of COVID-19 cases was reached on 20–28th March 2020. 
To reduce viral diffusion, a national lockdown was imposed 
from 9th March to 17th May 2020. On 3rd June 2020, key 
restrictive measures were withdrawn, and from May, no 
excess mortality was registered across the nation [9]. In the 
city of Torino, the number of daily COVID-19 diagnoses 
peaked at about 300/day from 20th March to 14th of April 
2020, and stably returned at < 10/day from 18th of June, with 
low incidence persisting throughout the summer.
Measurements
The study period was 1st January to 31st August, 2020 and 
2019. ED data were extracted in each center from the health 
record database in anonymized form. An automatic query 
was performed to extract the following data from each visit: 
patient gender, age, date of ED registration, triage prior-
ity, time of arrival, triage main symptom, date of discharge, 
patient destination (discharge vs hospital admission), and 
final diagnosis. Data extraction did not involve evaluation of 
individual medical charts or registration of additional per-
sonal/clinical information, and data treatment conformed to 
Italian D. Lgs. 196/2003 and European regulation 2016/679. 
Since the study focused on general ED flow analysis (sys-
tem-level) and not on individual patients, only utilized 
anonymized data, and was retrospective observational in 
nature, Ethic Committee approval was waived, as confirmed 
by the Hospital Board (prot. 101035, 23rd October 2020).
Triage codes and symptoms
Triage priority was based on standard triage nurse evaluation 
using color-codes following national indications. Briefly, a 
red code is attributed when a patient is suspected of having 
a life-threatening condition or vital sign modification, imply-
ing immediate evaluation. A yellow code is given when a 
patient displays signs/symptoms that could underlie a seri-
ous illness with evolving risk, implying medical visit within 
30 min. A green code is assigned when a patient does not 
present warning signs/symptoms, and whose medical evalu-
ation can be deferred. A white code is attributed when a 
patient complains symptoms that could be evaluated during 
an ambulatory medical visit in the following hours.
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Triage evaluation includes a structured interview by a 
trained nurse, also defining main triage symptom. From 
March 2020, systematic triage assessment of key COVID-
19 symptoms was also applied, to allow early allocation of 
patients satisfying criteria to a dedicated ED area. Color 
code evaluation was unchanged. In data analysis, the fol-
lowing main triage symptoms were queried: dyspnea, chest 
pain, abdominal pain, psychiatric symptom.
Diagnostic classification
Discharge diagnoses were grouped using the ICD-9-CM 
classification, with few modifications based on clinical rea-
soning. Within the ICD group “16–symptoms, signs, and 
ill-defined conditions”, selected diagnoses were analyzed 
per se because frequently leading to ED visits (syncope, 
unspecific chest pain), or were grouped within organ-spe-
cific categories (ESM Appendix Table 2). Fever and sepsis/
septic shock were grouped within infectious diseases, dysp-
nea was grouped within respiratory diseases, palpitations 
were grouped within cardiovascular diseases, and convul-
sions were grouped within neurological diseases. Pediatric 
patients were defined by age < 14 years. Based on the local 
practice of all participating centers, ICD-9-CM codes defin-
ing SARS-CoV-2 infection were: 79.82, 480.3 or V01.82.
Statistical analysis
For statistical analysis, the study focused on four 14-day 
periods in 2020, which were compared to the correspond-
ing periods in 2019: 31st March–13th April (climax of the 
first wave), 16th–29th June (early post-wave), 14th–27th 
July (mid post-wave) and 18th–31st August (late post-wave 
period). The last three study periods were chosen a priori to 
be evenly distributed, allowing two weeks of adaptation after 
withdrawal of lockdown measures.
Count data were expressed with absolute number and 
proportion. Using the Poisson regression, we estimated the 
percent change and its 95% confidence interval (CI) from 
the exponentiated Poisson regression coefficient. Type-III P 
values were used to assess whether the Poisson regression 
model with a specific variable was statistically significant (P 
value < 0.05). Data were displayed using locally estimated 
scatterplot smoothing (LOESS), in order better show data 
trend (smoothing span conservatively set at 14%). Extraction 
of count data and graphs were done with Microsoft Excel 
(Microsoft Corp., ver. 16.0), MedCalc (MedCalc Software 
Ltd, ver. 19.5.2), and all statistical analyses were performed 
using SPSS (IBM Corp., ver. 25.0).
Results
Visit number and characteristics
In the study centers, total ED visits were 147,446 from Janu-
ary to August 2020, and 214,868 in the corresponding period 
of 2019. The number of daily ED visits is shown in Fig. 1a. 
Trends were similar across all centers (ESM Appendix 
Fig. 1). The incidence of COVID-19 diagnoses identified 1st 
March to 15th May 2020 as the first wave period (Fig. 1b).
During the first wave peak, ED visits were reduced by 
66.4% compared to 2019 (P < 0.001; Table 1). The reduc-
tion was 69.8% during daytime (8 a.m. to 4 p.m.; P < 0.001), 
64.1% in the evening (4 p.m. to 0 a.m.; P < 0.001) and 58.6% 
during nighttime (P < 0.001). The reduction in ED visits was 
71.7% (P < 0.001) for patients aged < 50 years and 61.7% 
for patients aged > 75 years (P < 0.001). A maximum 89.4% 
reduction was found for pediatric patients (P < 0.001). The 
first wave peak reduction in ED visits was similar for female 
and male patients (64.4% and 68.4%; both P < 0.001).
The reduction in total ED visits persisted also after the 
first COVID-19 wave, by 25.4%, 25.3% and 23.5% (all 
P < 0.001) in the early, mid and late post-wave periods, 
respectively. In the post-wave periods, reductions were 
homogenous across daytime and adult patient age (ESM 
Appendix Table 3). ED visits for pediatric patients were 
substantially and persistently reduced in all post-wave 
periods, by 57.6%, 39.9% and 44.6% (all P < 0.001) in the 
early, mid and late post-wave periods, respectively. Reduc-
tions in ED visits were persistently larger for female than 
for male patients: 33.6% vs 17.5% in the early, 29.3% vs 
22.2% in the mid, 27.9% vs 19.1% in the late post-wave 
period (all P < 0.001).
Triage data
Within triage priority, most urgent/critical codes were 
unchanged in 2020 compared to 2019, both during and 
after the first wave (Fig. 1c). Significant reductions were 
observed for less urgent codes, both within the first wave 
peak and in the post-wave periods (Fig. 1d). The greatest 
reductions were observed for most deferrable cases (ESM 
Appendix Table 4). In the late post-wave period, yellow, 
green and white codes were persistently reduced by 19.4%, 
20.2% and 34.7% (all P < 0.001), respectively.
All main triage symptoms showed a statistically signifi-
cant reduction, both during and after the first wave (ESM 
Appendix Table 4). The lowest change was registered 
for dyspnea, which presented similar reductions during 
(13.8%; P = 0.011) and after (19.8%, P = 0.001; 15.9%, 
P = 0.016; 14.8%, P = 0.017) the first wave.
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ED diagnoses
During the first wave peak, all non-COVID-19 diagnoses 
showed a significant reduction compared to 2019 (Fig. 2 
and ESM Appendix Table 5), ranging from a minimum of 
27.2% (P < 0.001) for infectious diseases to a maximum 
of 80.8% (P < 0.001) for neurologic diseases. After the 
first wave, diagnoses of oncological, metabolic/endocrine 
and hematological diseases were statistically unchanged, 
in the early, mid and late periods. Infectious, psychiatric, 
neurological, non-COVID-19 respiratory, gastrointestinal, 
urological, obstetrical/gynecological diseases and trauma 
showed a significant reduction in all post-wave periods. 
In the late period, reductions ranged from a minimum of 
10.7% (P = 0.034) for psychiatric diseases to a maximum 
of 30.8% (P < 0.001) for infectious diseases. Cardiovas-
cular diseases and unspecific chest pain were statistically 
unchanged in the early post-wave period and reduced sub-
sequently (15.8% and 33.7% respectively in the late period, 
both P < 0.001).
Fig. 1  a Daily number of ED visits in 2020 (red) and 2019 (blue), 
from 1st January to 31st August. b Number of new daily diagnoses 
of COVID-19 in the Torino province, in 2020. c Daily number of red 
(most urgent/critical; red dots/line), yellow (urgent for evolutive risk; 
yellow dots/line) green (non-urgent, deferrable; green dots/line) and 
white codes (least urgent, deferrable to ambulatory clinic; light blue), 
in 2019. d Daily number of red, yellow, green and white codes, in 
2020 (Color figure online)
Table 1  ED visit count and 
corresponding % change in the 
selected periods
Period analyzed 2019 2020 % change (95% CI) P value
ED visit count ED visit count
First-wave peak
(31st Mar–13th Apr)
12,420 4168 66.4% (65.2–67.6) < 0.001
Early post-wave
(16th–29th Jun)
12,609 9404 25.4% (23.4–27.4) < 0.001
Mid post-wave
(14th–28th Jul)
11,768 8796 25.3% (23.2–27.3) < 0.001
Late post-wave
(18th–31st Aug)
11,365 8693 23.5% (21.3–25.6) < 0.001
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Hospital admissions
Total ED-disposed hospital admissions for non-COVID-19 
diseases are shown in Fig. 3a. Non-COVID-19 admissions 
were reduced by 39.5% (P < 0.001) during the first wave 
peak, and by 12.8% (P = 0.001), 6.3% (P = 0.104) and 12.2% 
(P = 0.001) in the early, mid and late post-wave period, 
respectively (ESM Appendix Table 6). The admission rate 
(Fig. 3b) reached a climax during the first wave, with a slight 
but persistent increase throughout the post-wave period (in 
the late period, 13.5% vs 11.9% in 2019).
Percent changes in hospital admissions for non-
COVID-19 diagnoses are shown in Fig. 4 and detailed in 
ESM Appendix Table 6. During the first wave peak, admis-
sions were significantly reduced for infectious, oncological, 
psychiatric, neurological, cardiovascular, gastrointestinal, 
urological, obstetric/gynecological diseases and syncope 
(Fig. 4a), ranging from a minimum of 43.6% (P < 0.001) for 
cardiovascular diseases to a maximum of 83.3% (P = 0.019) 
for syncope. In the post-wave period, hospital admissions 
were significantly reduced in the early period for psychiat-
ric, non-COVID-19 respiratory and obstetric/gynecological 
diseases (Fig. 4b), and in the late period for psychiatric and 
obstetric/gynecological diseases (Fig. 4d).
Discussion
This is the first study analyzing the long-term effects of 
COVID-19 on ED flows beyond the early diffusion phase 
and throughout the epidemiological nadir observed during 
the summer of 2020 in European countries [2, 4, 5]. Reduc-
tions, during and after the first wave peak, mostly derived 
from non-urgent codes, i.e. cases amenable to deferrable 
evaluation and potentially indicative of ED misuse. Instead, 
the number of urgent codes was unchanged. During the wave 
Fig. 2  Percent change (with 95% CI) in ED diagnoses other than 
COVID-19, during a  the first wave peak (31st March–13th April 
2020), b early post-wave period (16th–29th June 2020, c mid post-
wave period (14th–27th July 2020), and d  late post-wave period 
(18th–31st August 2020), compared to the corresponding periods of 
2019
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peak, changes were more pronounced during daytime and in 
younger patients, also indicating a prevalent effect on defer-
rable cases. The drop was very substantial and persistent 
for pediatric patients, as previously reported [10, 11]. In the 
post-wave periods, the reduction in ED visits was also more 
pronounced for female patients, indicating gender-specific 
differential effects.
In line with previous reports, we also found a major 
reduction in cardiovascular and neurologic diagnoses dur-
ing the wave peak, but moderate reductions also persisted 
in the post-wave phase [5–8]. Related hospital admissions 
normalized after the peak, potentially indicating a prevalent 
reduction in milder cases. For several other conditions, the 
post-wave period was also characterized by a long-lasting 
reduction in ED diagnoses, while admissions were nor-
malized. Overall, these data indicate potential ED under-
treatment as a COVID-19 side effect, but also that several 
patients may have been managed outside EDs [12]. Both 
ED diagnoses and admissions for onco-hematological and 
metabolic/endocrine diseases returned to pre-COVID-19 
standards early after the first wave, potentially indicating 
lower disposal or efficiency of alternative care to EDs for 
these conditions.
Admission data indicate that, in spite of a long-last-
ing decline in ED visits, the number of hospital beds 
needed for non-COVID-19 diseases after a wave is largely 
unchanged, especially for patients affected by metabolic/
endocrine and hematologic diseases. Results also show 
that during a pandemic peak, the admission rate for non-
COVID-19 conditions reaches a climax, likely due to burn-
out of ED resources by COVID-19, increased difficulties in 
outpatient management, loss of beds in ED-driven obser-
vation units, and increased proportion of patients with 
more severe conditions seeking ED care.
While facing a second COVID-19 wave worldwide, 
study results have practical implications. Reduced num-
bers of patients accessing EDs constitutes an unprece-
dented opportunity to preserve or even increase the quality 
of ED care. However, additional barriers may counterbal-
ance the potential benefits of visit reduction, such as the 
necessity of pre-triage, additional testing, and patient dis-
tancing. Unless well designed strategies are put in place, 
insufficient ED facilities and long turnaround times for 
testing will prevail, leading to dangerous overcrowding 
and increased boarding time.
The current study does not provide data on the causes 
leading to ED visit reduction, and quantification of patients 
inappropriately avoiding or delaying ED visits was not pos-
sible. Differential effect on women, pediatric patients and 
triage codes indicate that this is likely a multifactorial phe-
nomenon, warranting further category-specific investigation.
The study has limitations. First, results essentially apply 
to areas experiencing a clear-cut viral wave followed by 
nadir. Second, sub-analyses of ED discharge diagnosis 
must be interpreted with caution. Such diagnosis, chosen 
by the attending physician as the prevalent diagnosis, may 
not correspond to subsequent medical evaluations and may 
represent the prevalent, but not the only, clinically mean-
ingful condition. Third, sub-analyses are less powered for 
infrequent disease categories (thus leading to type II error). 
Fig. 3  a Daily hospital admissions and b hospitalization rate from 1st 
January to 31st August 2020 (red dots/line) and 2019 (blue dots/line). 
c Daily number of new COVID-19 diagnoses in the Torino province 
in the same period of 2020 (Color figure online)
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Fourth, visits for most severe obstetrical/gynecological 
diagnoses, traumas and pediatric patients may be under-
represented (selection bias), because locally, these cases 
are frequently conducted to the corresponding specialty ED 
not included in the present study. In general, reductions in 
ED visits, diagnoses and hospital admissions may be less 
pronounced in referral centers accepting most severe cases 
from large areas.
In conclusion, we found that the first wave of COVID-
19 modified ED flows in the long-term, with measurable 
changes during the summer of 2020, after withdrawal of 
lockdown measures and return of local COVID-19 incidence 
to a minimum. Reductions in total visits were dragged by 
non-urgent triage codes, and more pronounced for female 
and pediatric patients. Hospital admissions acutely declined 
during the first wave, but rapidly returned post-peak almost 
to previous standards. Admissions for certain conditions 
(metabolic/endocrine and hematologic diseases), however, 
were unchanged even during the peak, indicating that a suf-
ficient number of hospital beds for non-COVID-19 diseases 
must be guaranteed throughout a peak, rapidly reverting 
to standard numbers after the peak resolution. Finally, this 
unprecedented reduction in ED visits should be regarded as 
a proof-of-concept that ED overuse and overcrowding are 
hard yet affordable endpoints for strong healthcare policies.
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